 BOSTON, Sept. 09, 2022 GLOBE NEWSWIRE -- Compass Therapeutics, Inc. Nasdaq: CMPX, a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer, today announced that the Company will participate in the 24th Annual H.C. Wainwright Global Investment Conference, which is taking place in New York City September 12 14, 2022. 